These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32008042)

  • 21. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
    Bae T; Hur JW; Kim D; Hur JK
    Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
    Prykhozhij SV; Caceres L; Berman JN
    Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictable and precise template-free CRISPR editing of pathogenic variants.
    Shen MW; Arbab M; Hsu JY; Worstell D; Culbertson SJ; Krabbe O; Cassa CA; Liu DR; Gifford DK; Sherwood RI
    Nature; 2018 Nov; 563(7733):646-651. PubMed ID: 30405244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expanding footprint of CRISPR/Cas9 in the plant sciences.
    Schaeffer SM; Nakata PA
    Plant Cell Rep; 2016 Jul; 35(7):1451-68. PubMed ID: 27137209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
    Bennett EP; Petersen BL; Johansen IE; Niu Y; Yang Z; Chamberlain CA; Met Ö; Wandall HH; Frödin M
    Nucleic Acids Res; 2020 Dec; 48(21):11958-11981. PubMed ID: 33170255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Portable CRISPR-Cas9
    Goh YJ; Barrangou R
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33397707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas system for yeast genome engineering: advances and applications.
    Stovicek V; Holkenbrink C; Borodina I
    FEMS Yeast Res; 2017 Aug; 17(5):. PubMed ID: 28505256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 30. CRISPR/Cas-based genome engineering in natural product discovery.
    Tong Y; Weber T; Lee SY
    Nat Prod Rep; 2019 Sep; 36(9):1262-1280. PubMed ID: 30548045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SpCas9- and LbCas12a-Mediated DNA Editing Produce Different Gene Knockout Outcomes in Zebrafish Embryos.
    Meshalkina DA; Glushchenko AS; Kysil EV; Mizgirev IV; Frolov A
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32635161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrated CRISPR Bombyx mori genome editing system with improved efficiency and expanded target sites.
    Ma S; Liu Y; Liu Y; Chang J; Zhang T; Wang X; Shi R; Lu W; Xia X; Zhao P; Xia Q
    Insect Biochem Mol Biol; 2017 Apr; 83():13-20. PubMed ID: 28189747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPRclassify: Repeat-Based Classification of CRISPR Loci.
    Nethery MA; Korvink M; Makarova KS; Wolf YI; Koonin EV; Barrangou R
    CRISPR J; 2021 Aug; 4(4):558-574. PubMed ID: 34406047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducible CRISPR genome-editing tool: classifications and future trends.
    Dai X; Chen X; Fang Q; Li J; Bai Z
    Crit Rev Biotechnol; 2018 Jun; 38(4):573-586. PubMed ID: 28936886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing.
    Liu R; Liang L; Freed EF; Gill RT
    Trends Biotechnol; 2021 Mar; 39(3):262-273. PubMed ID: 32828556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CRISPR-Cas9 Genome Editing System: Not as Precise as Previously Believed.
    Mattei TA
    World Neurosurg; 2018 Oct; 118():377-378. PubMed ID: 30114543
    [No Abstract]   [Full Text] [Related]  

  • 37. CRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications.
    Molla KA; Yang Y
    Trends Biotechnol; 2019 Oct; 37(10):1121-1142. PubMed ID: 30995964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Tale of Two Moieties: Rapidly Evolving CRISPR/Cas-Based Genome Editing.
    Yang L; Chen J
    Trends Biochem Sci; 2020 Oct; 45(10):874-888. PubMed ID: 32616331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo CRISPR editing with no detectable genome-wide off-target mutations.
    Akcakaya P; Bobbin ML; Guo JA; Malagon-Lopez J; Clement K; Garcia SP; Fellows MD; Porritt MJ; Firth MA; Carreras A; Baccega T; Seeliger F; Bjursell M; Tsai SQ; Nguyen NT; Nitsch R; Mayr LM; Pinello L; Bohlooly-Y M; Aryee MJ; Maresca M; Joung JK
    Nature; 2018 Sep; 561(7723):416-419. PubMed ID: 30209390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AcrPred: A hybrid optimization with enumerated machine learning algorithm to predict Anti-CRISPR proteins.
    Dao FY; Liu ML; Su W; Lv H; Zhang ZY; Lin H; Liu L
    Int J Biol Macromol; 2023 Feb; 228():706-714. PubMed ID: 36584777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.